Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients

被引：6

作者：

Bani-Sadr, Firouze ^{[1
]}

Miailhes, Patrick ^{[2
]}

Rosenthal, Eric ^{[3
]}

Yazdanpanah, Yazdan ^{[4
]}

Boyer, Laurence ^{[5
]}

Zucman, David ^{[6
]}

Cacoub, Patrice ^{[7
]}

Perronne, Christian ^{[8
]}

Pol, Stanislas ^{[9
]}

Carrat, Fabrice ^{[1
]}

机构：

[1] Univ Paris 06, Grp Hosp Univ Est, INSERM, U 707, Paris, France

[2] Ctr Hosp Univ, Hotel Dieu, Lyon, France

[3] Ctr Hosp Univ Nice, Nice, France

[4] Ctr Hosp Tourcoing, Tourcoing, France

[5] Ctr Hos Univ Nancy, Nancy, France

[6] Hop Foch, Suresnes, France

[7] Univ Paris 06, Grp Hosp Univ Est, UMR 7087, Paris, France

[8] Univ Versailles, Ctr Hosp Univ Raymond Poincare, Garches, France

[9] Univ Paris 05, Grp Hosp Univ Ouest, INSERM, U370, Paris, France

来源：

AIDS | 2008年 / 22卷 / 10期

关键词：

D O I：

10.1097/QAD.0b013e3282fbd203

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1234 / 1236

页数：3

共 9 条

[1] The relationship between nevirapine plasma concentrations and abnormal liver function tests [J].

Almond, LM ;

Boffito, M ;

Hoggard, PG ;

Bonora, S ;

Raiteri, R ;

Reynolds, HE ;

Garazzino, S ;

Sinicco, A ;

Khoo, SH ;

Back, DJ ;

Di Perri, G .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (07) :716-722

[2] Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis C [J].

Barreiro, Pablo ;

Rodriguez-Novoa, Sonia ;

Labarga, Pablo ;

Ruiz, Andres ;

Jimenez-Nacher, Inmaculada ;

Martin-Carbonero, Luz ;

Gonzalez-Lahoz, Juan ;

Soriano, Vincent .

JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (07) :973-979

[3] Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy [J].

Martínez, E ;

Blanco, JL ;

Arnaiz, JA ;

Pérez-Cuevas, JB ;

Mocroft, A ;

Cruceta, A ;

Marcos, MA ;

Milinkovic, A ;

García-Viejo, MA ;

Mallolas, J ;

Carné, X ;

Phillips, A ;

Gatell, JM .

AIDS, 2001, 15 (10) :1261-1268

[4] Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients [J].

Myers, RP ;

Benhamou, Y ;

Imbert-Bismut, F ;

Thibault, V ;

Bochet, M ;

Charlotte, F ;

Ratziu, V ;

Bricaire, F ;

Katlama, C ;

Poynard, T .

AIDS, 2003, 17 (05) :721-725

[5] Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression [J].

Negredo, E ;

Cruz, L ;

Paredes, R ;

Ruiz, L ;

Fumaz, CR ;

Bonjoch, A ;

Gel, S ;

Tuldrà, A ;

Balagué, M ;

Johnston, S ;

Arnó, A ;

Jou, A ;

Tural, C ;

Sirera, G ;

Romeu, J ;

Clotet, B .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (04) :504-510

[6] Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients [J].

Seminari, E ;

Gentilini, G ;

Galli, L ;

Hasson, H ;

Danise, A ;

Carini, E ;

Dorigatti, F ;

Soldarini, A ;

Lazzarin, A ;

Castagna, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (04) :790-792

[7] Care of patients coinfected with HIV and hepatitis C virus:: 2007 updated recommendations from the HCV-HIV International Panel [J].

Soriano, Vincent ;

Puoti, Massimo ;

Sulkowski, Mark ;

Cargnel, Antonietta ;

Benhamou, Yves ;

Peters, Marion ;

Mauss, Stefan ;

Brau, Norbert ;

Hatzakis, Angelos ;

Pol, Stanislas ;

Rockstroh, Juergen .

AIDS, 2007, 21 (09) :1073-1089

[8]

Tutor-Crespo MJ, 2004, J PHARM PHARM SCI, V7, P353

[9] Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction [J].

Wyles, DL ;

Gerber, JG .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (01) :174-181

← 1 →